Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT01079481 · COMPLETED
Trial details
- NCT number
- NCT01079481
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-05-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.